Nampt (Visfatin/PBEF) (human) ELISA Kit
AG-45A-0006YEK
Product group Chemicals
Overview
- SupplierAdipoGen Life Sciences
- Product NameNampt (Visfatin/PBEF) (human) ELISA Kit
- Delivery Days Customer10
- CertificationResearch Use Only
- UNSPSC12352200
References
- Visfatin is present in bovine mammary epithelial cells, lactating mammary gland and milk, and its expression is regulated by cAMP pathway: T. Yonezawa, et al.; FEBS Lett. 580, 6635 (2006)
- Molecular characteristics of serum visfatin and differential detection by immunoassays: A. Koerner, et al.; J. Clin. Endocrinol. Metab. 92, 4783 (2007)
- Serum levels of the adipokine visfatin are increased in pre-eclampsia: M. Fasshauer, et al.; Clin. Endocrinol. 69, 69 (2008)
- Correlation of circulating full-length visfatin (PBEF/Nampt) with metabolic parameters in subjects with and without diabetes: a cross-sectional study: R. Retnakaran, et al.; Clin. Endocrinol. 69, 885 (2008)
- Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery: M. M. Swarbrick, et al.; Diabetologia 51, 1901 (2008)
- Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis: M. Ziegelmeier, et al.; Metabolism 57, 1414 (2008)
- Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy: A.A. Alghasham & Y.A. Barakat; Saudi Med. J. 29, 185 (2008)
- Ethnic-specific Correlations of Visfatin With Circulating Markers of Endothelial Inflammation and Function: M. Reimann, et al.; Obesity 17, 2210 (2009)
- Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis: F. Lovren, et al.; Am. J. Physiol. Endocrinol. Metab. 296, E1440 (2009)
- Circulating visfatin in chronic obstructive pulmonary disease: X. Liu, et al.; Nutrition 25, 373 (2009)